Skip to main content
SpringerLink
Log in

Mutations of LH and FSH receptors

  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Gonadotropins control male and female gonadal function by acting through specific recptors. The recent description of several mutations in LH and FSH receptors has significantly improved our understanding of the pathophisiology of several sexual disorder. Both gain- and loss-of-function germline mutations leading to constitutive receptor activation or to hormone resistance have been described. The clinical impact of these mutant receptors can be markedly different, depending upon the sex of the affected patient and the degree of functional alteration. Numerous mutations were described in LH receptor gene. Constitutive activation of this receptor leads to male-limited precocious pseudopuberty, whereas hypergonadotropic hypogonadism is the clinical phenotype of LH resistance. On the other hand, few mutations of FSH receptor were described so far. Inactivating mutations of FSH receptor are involved in some cases of hypergonadotropic hypogonadism with a more severe impairment of fertility in female patients. Only one gain-of-function mutation of FSH receptor was reported to maintain fertility in one hypophysectomized man. This review is focused on the known genetic alterations of gonadotropic receptors in humans and their impact on male sexual differentiation and fertility.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Spiegel A.M. Mutations in G proteins and G protein-coupled receptors in endocrine disease. J. Clin. Endocrinol. Metab. 1996, 81: 2434–2442.

    CAS  PubMed  Google Scholar 

  2. Minegishi T., Nakamura K., Takakura Y., Miyamoto K., Hasegawa Y., Ibuki Y., Igarashi M. Cloning and sequencing of human LH/hCG receptor cDNA. Biochem. Biophys. Res. Commun. 1990, 172: 1049–1054.

    Article  CAS  PubMed  Google Scholar 

  3. Minegishi T., Nakamura K., Takakura Y., Ibuki Y., Igarashi M. Cloning and sequencing of human FSH receptor cDNA. Biochem. Biophys. Res. Commun. 1991, 175: 1125–1130.

    Article  CAS  PubMed  Google Scholar 

  4. Rousseau-Merck M.F., Misrahi M., Atger M., Loosfelt H., Milgrom E., Berger R. Localization of the human LH (luteinizing hormone) receptor gene to chromosome 2p21. Cytogenet. Cell Genet. 1990, 54: 77–79.

    Article  CAS  PubMed  Google Scholar 

  5. Gromoll J., Ried T., Holtgreve-Grez H., Nieschlag E., Gudermann T. Localization of the human follicle-stimulating hormone receptor to chromosome 2p21 using a genomic probe comprising exon 10. J. Mol. Endocrinol. 1994, 12: 265–271.

    Article  CAS  PubMed  Google Scholar 

  6. Shenker A., Laue L., Kosugi S., Merendino J. Jr., Minegishi T., Kutler J. Jr. A costitutively activating mutation of the lutenizing hormone receptor in familial male precocious puberty. Nature 1993, 365: 652–654.

    Article  CAS  PubMed  Google Scholar 

  7. Kremer H., Mariman E., Otten B.J., Moll G. Jr., Stoelinga G.B., Wit J.M., Jansen M., Drop S.L., Faas B., Ropers H.H. Cosegregation of missense muitations of luteinizing hormone receptor gene with familial male-limited precocious puberty. Hum. Mol. Genet. 1993, 2: 1779–1783.

    Article  CAS  PubMed  Google Scholar 

  8. Kraaij R., Post M., Kremer H., Milgrom E., Epping W., Brunner H.G. A missense mutation in the second transmembrane segment of the luteinizing hormone receptor causes familial male-limited precocious puberty. J. Clin. Endocrinol. Metab. 1995, 80: 3168–3172.

    CAS  PubMed  Google Scholar 

  9. Laue L.L., Chan W.Y., Hsueh A.J.W., Kudo M., Hsu S.Y., Wu S.-M. Genetic heterogeneity of costitutively activating mutations of the human luteinzing hormone receptor in familial male-limited precocious puberty. Proc. Natl. Acad. Sci. USA 1995, 92: 1906–1910.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  10. Gromoll J., Simoni M., Nieschlag E. An activating mutation of the follicle-stimulating hormone receptor autonomously sustain spermatogenesis in a hypophysectomized man. J. Clin. Endocrinol. Metab. 1996, 81: 1367–1370.

    CAS  PubMed  Google Scholar 

  11. Themmen A.P.N., Brunner H.G. Luteinizing hormone receptor mutations and sex differentiation. Eur. J. Endocrinol. 1996, 134: 533–540.

    Article  CAS  PubMed  Google Scholar 

  12. Kremer H., Kraaij R., Toledo S.P., Post M., Fridman J.B., Hayashida C.Y., van Reen M., Milgrom E., Ropers H.H., Mariman E.Z. Male pseudohermaphroditism due to a homozygous missense mutation of the luteinizing hormone receptor gene. Nat. Genet. 1995, 9: 160–164.

    Article  CAS  PubMed  Google Scholar 

  13. Laue L.L., Wu S.-M., Kudo M., Bourdony C.J., Cutler G.B. Jr., Hsueh A.J.W., Chan W.Y. Compound heterozygous mutations of the luteinizing hormone receptor gene in Leydig cell hypoplasia. Mol. Endocrinol. 1996, 10: 987–997.

    CAS  PubMed  Google Scholar 

  14. Aittomaki K., Dieguez Lucena J.L., Pakarinen P., Sistonen P., Tapananinen J., Gromoll J., Kaskikari R., Sankila E.-M., Lehvaslaiho H., Engel A.R., Nieschlag E., Huhtaniemi I., de la Chapelle A. Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell 1995, 82: 959–968.

    Article  CAS  PubMed  Google Scholar 

  15. Tapananinen J.S., Aittomaki K., Min J., Vaskivuo T., Huhtaniemi I.T. Men homozygous for an inactivating mutation of the follicle-stimulating hormone (FSH) receptor gene present variable suppression of spermatogenesis and fertility. Nat. Genet. 1997, 15: 205–206.

    Article  Google Scholar 

  16. Wu S.M., Leschek E.W., Rennert O.M., Chan W.Y. Luteinizing hormone receptor mutations in disorders of sexual development and cancer. Front. Biosci. 2000, 5: D343–352.

    Article  CAS  PubMed  Google Scholar 

  17. Rosenthal I.M., Refetoff S., Rich B., Burness R.B., Sunthornthepvarakul T., Parma J., Rosenfield R.L. Response to challenge with gonadotropin-releasing hormone agonist in a mother and her two sons with a costitutively activating mutation of the luteinizing hormone receptor. A clinical research center study. J. Clin. Endocrinol. Metab. 1996, 81: 3802–3806.

    CAS  PubMed  Google Scholar 

  18. Liu G., Doranteau L., Carel J.C., Monroe J., Doyle D.A., Shenker A. Leydig-cell tumors caused by an activating mutation of the gene encoding the luteinizing hormone receptor. N. Engl. J. Med. 1999, 341: 1731–1736.

    Article  CAS  PubMed  Google Scholar 

  19. Latronico A.C., Anasti J., Arnhold I.J.P., Rapaport R., Mendonca B.B., Bloise W., Castro M., Tsigos C., Chrousos G.P. Testicular and ovarian resistance to luteinizing hormone caused by inactivating mutations of the luteinizing hormone-receptor gene. N. Engl. J. Med. 1996, 334: 507–512.

    Article  CAS  PubMed  Google Scholar 

  20. Misrahi M., Meduri G., Pissard., Bouvattier C., Beau I., Loosfelt H., Jolivet A., Rapaport R., Milgrom E., Bougneres P. Comparison of immunohistochemical and molecular features with the phenotype in a case of incomplete male pseudohermaphroditism associated with a mutation of the luteinizing hormone receptor. J. Clin. Endocrinol. Metab. 1997, 82: 2159–2165.

    CAS  PubMed  Google Scholar 

  21. Latronico A.C., Chan Y., Arnhold I.J.P., Liu X., Mendonca B.B., Segaloff D.L. A homozigous microdeletion in helix 7 of the luteinizing hormone receptor associated with familial testicular and ovarian resistance is due both to decreased cell surface expression and impaired effector activation by the cell surface receptor. Mol. Endocrinol. 1998, 12: 442–450.

    Article  CAS  PubMed  Google Scholar 

  22. Stavrou S.S., Zhu Y.-S., Cai L.-Q., Katz M.D., Herrera C., Defillo-Ricart M., Imperato-McGinley J. A novel mutation of the human luteinizing hormone receptor in 46XY and 46XX sisters. J. Clin. Endocrinol. Metab. 1998, 83: 2091–2098.

    CAS  PubMed  Google Scholar 

  23. Wu S.-M., Hallermeier K.M., Laue L., Brain C., Berry A.C., Grant D.B., Griffin J.E., Wilson J.D., Cutler G.C. Jr., Chan W.-Y. Inactivation of the luteinizing hormone/chorionic gonadotropin receptor by an insertional mutation in Leydig cell hypoplasia. Mol. Endocrinol. 1998, 12: 1651–1660.

    Article  CAS  PubMed  Google Scholar 

  24. Martens J.W.M., Verhoef-Post M., Abelin N., Ezabella M., Toledo S.P.A., Brunner H.G., Themmen A.P.N. A homozygous mutation in the luteinizing hormone receptor causes partial Leydig cell hypoplasia: correlation between receptor activity and phenotype. Mol. Endocrinol. 1998, 12: 775–783.

    Article  CAS  PubMed  Google Scholar 

  25. Arnhold I.J.P., Latronico A.C., Batista M.C., Izzo C.R., Mendonca B.B. Clinical features of women with resistance to luteinizing hormone. Clin. Endocrinol. 1999, 51: 701–707.

    Article  CAS  Google Scholar 

  26. Gromoll J., Eiholzer U., Nieschlag E., Simoni M. Male hypogonadism caused by homozygous deletion of exon 10 of luteinizing hormone (LH) receptor: differential action of human chorionic gonadotropin and LH. J. Clin Endocrinol. Metab. 2000, 85: 2281–2285.

    Article  CAS  PubMed  Google Scholar 

  27. Zhang F.P., Kero J., Huhtaniemi I. The unique exon 10 of the luteinizing hormone receptor is necessary for expression of the receptor protein at the plasma membrane in the human luteinizing hormone receptor, but deleterious when inserted into the human follicle-stimulating hormone receptor. Mol. Cell. Endocrinol. 1998, 142: 165–174.

    Article  CAS  PubMed  Google Scholar 

  28. Kotlar T.J., Young R.H., Albanese C., Crowley W.F. Jr., Scully R.E., Jameson J.L. A mutation in the follicle-stimulating hormone receptor occurs frequently in human ovarian sex cord tumors. J. Clin. Endocrinol. Metab. 1997, 82: 1020–1026.

    CAS  PubMed  Google Scholar 

  29. Fuller P.J., Verity K., Shen Y., Mamers P., Jobling T., Burger H.G. No evidence of a role for mutations or polymorphysm of the follicle-stimulating hormone receptor in ovaria granulosa cell tumors. J. Clin. Endocrinol. Metab. 1998, 83: 274–279.

    CAS  PubMed  Google Scholar 

  30. Kotlar T., Young R.H., Albanese C., Crowley W.F.Jr., Scully R.E., Jameson J.L. Absence of mutations in the FSH receptor in ovarian granulosa cell tumors. J. Clin. Endocrinol. Metab. 1998, 83: 3001.

    Article  CAS  PubMed  Google Scholar 

  31. Ligtemberg M.J., Siers M., Themmen A.P.N., Hanselaar T.G., Willemsen W., Brunner H.G. Analysis of mutations in genes of the follicle-stimulating hormone receptor signaling pathway in ovarian granulosa cell tumors. J. Clin. Endocrinol. Metab. 1999, 84: 2233–2234.

    Google Scholar 

  32. Huhtaniemi I.T., Aittomaki K. Mutations of follicle stimulating hormone and its receptor; effect on gonadal function. Eur. J. Endocrinol. 1998, 138: 473–481.

    Article  CAS  PubMed  Google Scholar 

  33. Layman L.C., McDonough P.G. Mutations of follicle stimulating hormone-β and its in human and mouse: genotype/phenotype. Mol. Cell. Endocrinol. 2000, 131: 9–17.

    Article  Google Scholar 

  34. Aittomaki K., Herva R., Stenman U.H., Juntunen K., Ylostalo P., Hovatta O., de la Chapelle A. Clinical features of primary ovarian failure caused by a point mutation in the follicle-stimulating hormone receptor gene. J. Clin. Endocrinol. Metab. 1996, 81: 3722–3726.

    CAS  PubMed  Google Scholar 

  35. Layman L.C., Amde S., Cohen D.P., Jin M., Xie J. The Finnish follicle-stimulating hormone receptor gene mutation is rare in North American women with 46, XX ovarian failure. Fertil. Steril. 1998, 69: 300–302.

    Article  CAS  PubMed  Google Scholar 

  36. Jiang M., Aittomaki K., Nilsson C., Pakarinen P., Iitia A., Torresani T., Simonsen H., Goh V., Pettersson K., de la Chapelle A., Huhtaniemi I.T. The frequency of an inactivating point mutation (566C→T) of the human follicle-stimulating hormone receptor gene in four populations using allele-specific hybridization and time-resolved fluorometry. J. Clin. Endocrinol. Metab. 1998, 83: 4338–4343.

    CAS  PubMed  Google Scholar 

  37. Beau I., Touraine P., Meduri G., Gougeon A., Desroches A., Matuchansky C., Milgrom E., Kuttenn F, Mishahi M. A novel phenotype related to partial loss of function mutations of the follicle stimulating hormone receptor. J. Clin. Invest. 1998, 102: 1352–1359.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  38. Touraine P., Beau I., Gougeon A., Meduri G., Desroches A., Pichard C., Detoeuf M., Paniel B., Prieur M., Zorn J.-R., Milgrom E., Kuttenn F., Misrahi M. New natural inactivating mutations of the follicle stimulating hormone receptor: correlation between receptor function and phenotype. Mol. Endocrinol. 1999, 13: 1844–1854.

    Article  CAS  PubMed  Google Scholar 

  39. Kumar T.R., Wang Y., Lu N., Matzuk M.M. Follicle stimulating hormone is required for ovarian follicle maturation but not male fertility. Nat. Genet. 1997, 15: 201–204.

    Article  CAS  PubMed  Google Scholar 

  40. Abel M.H., Wootton A.N., Wilkins V., Huhtaniemi I., Knight P.G., Charlton H.M. The effect of a null mutation in the follicle-stimulating hormone receptor gene on mouse reproduction. Endocrinology 2000, 141: 1795–1803.

    CAS  PubMed  Google Scholar 

  41. Tuerlings J.H., Ligtenberg M.J., Kremer J.A., Siers M., Meuleman E.J., Braat D.D., Hoefsloot L.H., Merkus H.M., Brunner H.G. Screening male intracytoplasmatic sperm injections candidates for mutations of the follicle stimulating hormone receptor gene. Hum. Reprod. 1998, 13: 2098–2101.

    Article  CAS  PubMed  Google Scholar 

  42. Simoni M., Gromoll J., Hoppner W., Kamischke A., Kraffl T., Stahle D., Nieschlag E. Mutational analysis of the follicle stimulating hormone (FSH) Receptor in normal and infertile men: identification and characterization of two discrete FSH receptor isoform. J. Clin. Endocrinol. Metab. 1999, 84: 751–755.

    CAS  PubMed  Google Scholar 

  43. Simoni M., Gromoll J., Nieschlag E. The follicle stimulating hormone receptor: biochemistry, molecular biology, physiology, and pathophysiology. Endocr. Rev. 1997, 18: 739–773.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Endocrine Sciences, University of Milan, Ospedale Maggiore IRCCS, Via F. Sforza 35, 20145, Milano, Italy

    P. Beck-Peccoz & R. Romoli

  2. Laboratorio di Ricerche Endocrinologiche, Istituto Auxologico Italiano IRCCS, Milano, Italy

    L. Persani

Authors
  1. P. Beck-Peccoz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. Romoli
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. L. Persani
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to P. Beck-Peccoz.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Beck-Peccoz, P., Romoli, R. & Persani, L. Mutations of LH and FSH receptors. J Endocrinol Invest 23, 566–572 (2000). https://doi.org/10.1007/BF03343777

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03343777

Key-words

Search

Navigation